{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:53:01Z","timestamp":1765731181972,"version":"3.48.0"},"reference-count":62,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,5,3]]},"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The objective of this systematic review is to identify and summarise studies which examine epigenetic biomarkers in patients with Barrett\u2019s oesophagus (BO) and their association with progression to oesophageal adenocarcinoma (OADC). BO is a precursor lesion for OADC. There is no clinical test to predict patients who are likely to progress to OADC. An epigenetic biomarker could predict patients who are at high risk of progression from BO to OADC which could facilitate earlier diagnosis and spare those unlikely to develop cancer from regular invasive surveillance endoscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A systematic search was conducted of the following databases: MEDLINE, MEDLINE in Process, EMBASE, Cochrane Central, ISI Conference Proceedings Citation Index and the British Library\u2019s ZETOC. Studies were conducted in secondary and tertiary care settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>All studies measuring epigenetic change in patients over 18 years old who progressed from non-dysplastic BO to OADC were included. Genetic, in vitro and studies which did not measure progression in the same patient cohort were excluded. Study inclusion and risk of bias of individual eligible studies were assessed in duplicate by two reviewers using a modified Quality in Prognostic Studies tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>14 studies met the inclusion criteria. 42 epigenetic markers were identified, and 5 studies developed models aiming to predict progression to OADC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The evidence from this systematic review is suggestive of a role for p16 as an epigenetic biomarker for the progression of BO to OADC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Prospero number<\/jats:title>\n                    <jats:p>CRD42016038654.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-020427","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T05:25:20Z","timestamp":1530336320000},"page":"e020427","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett\u2019s oesophagus to oesophageal adenocarcinoma"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-9138","authenticated-orcid":false,"given":"Tom","family":"Nieto","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire L","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Dretzke","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Bayliss","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm James","family":"Price","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Dilworth","sequence":"additional","affiliation":[{"name":"Department of Surgery, Heart of England Foundation Trust and Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D","family":"Beggs","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Tucker","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Birmingham, Birmingham, UK"},{"name":"Department of Surgery, Heart of England Foundation Trust and Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,6,30]]},"reference":[{"key":"2025121408474956000_8.6.e020427.1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305372"},{"key":"2025121408474956000_8.6.e020427.2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/70.1.1"},{"key":"2025121408474956000_8.6.e020427.3","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.028076"},{"key":"2025121408474956000_8.6.e020427.4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers2031379"},{"key":"2025121408474956000_8.6.e020427.5","unstructured":"NCI. Surveillance, epidemiology and end results programme database: NC Institute, 2014."},{"key":"2025121408474956000_8.6.e020427.6","unstructured":"CRUK. Cancer Research UK Oesophageal Cancer Survival Statistics. 2011 http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/oesophageal-cancer\/survival (cited 1st Jun 2016)."},{"key":"2025121408474956000_8.6.e020427.7","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.322"},{"key":"2025121408474956000_8.6.e020427.8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300730"},{"key":"2025121408474956000_8.6.e020427.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2007.07.019"},{"key":"2025121408474956000_8.6.e020427.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808145"},{"key":"2025121408474956000_8.6.e020427.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2005.06.047"},{"key":"2025121408474956000_8.6.e020427.12","doi-asserted-by":"publisher","DOI":"10.1038\/nature02625"},{"key":"2025121408474956000_8.6.e020427.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013361","article-title":"Epigenetic biomarkers in progression from non-dysplastic Barrett\u2019s oesophagus to oesophageal adenocarcinoma: a systematic review protocol","volume":"6","author":"Nieto","year":"2016","journal-title":"BMJ Open"},{"key":"2025121408474956000_8.6.e020427.14","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.22"},{"key":"2025121408474956000_8.6.e020427.15","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-008-0633-5"},{"key":"2025121408474956000_8.6.e020427.16","doi-asserted-by":"publisher","DOI":"10.1007\/10350-007-0302-x"},{"key":"2025121408474956000_8.6.e020427.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.11.009"},{"key":"2025121408474956000_8.6.e020427.18","first-page":"6820","article-title":"Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma","volume":"62","author":"Sato","year":"2002","journal-title":"Cancer Res"},{"key":"2025121408474956000_8.6.e020427.19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1835"},{"key":"2025121408474956000_8.6.e020427.20","unstructured":"Matthews G . Enhanced Neoplasia Detection and Cancer Prevention in Chronic Colitis (ENDCaP-C): NIHR, 2013."},{"key":"2025121408474956000_8.6.e020427.21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/CBM-130355","article-title":"A systematic review of hypermethylation of p16 gene in esophageal cancer","volume":"13","author":"Xu","year":"2013","journal-title":"Cancer Biomark"},{"key":"2025121408474956000_8.6.e020427.22","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1007\/s13277-014-2276-3","article-title":"Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies","volume":"35","author":"Zhao","year":"2014","journal-title":"Tumour Biol"},{"key":"2025121408474956000_8.6.e020427.23","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.7314\/APJCP.2014.15.9.3921","article-title":"Association between Ras association domain family 1A promoter methylation and esophageal squamous cell carcinoma: a meta-analysis","volume":"15","author":"Yang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"2025121408474956000_8.6.e020427.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107598","article-title":"Association of promoter methylation of RUNX3 gene with the development of esophageal cancer: a meta analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"2025121408474956000_8.6.e020427.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.03.087"},{"key":"2025121408474956000_8.6.e020427.26","first-page":"1","article-title":"The microRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis","volume":"2014","author":"Fu","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"2025121408474956000_8.6.e020427.27","doi-asserted-by":"crossref","first-page":"11595","DOI":"10.1007\/s13277-014-2350-x","article-title":"Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol"},{"key":"2025121408474956000_8.6.e020427.28","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu449"},{"key":"2025121408474956000_8.6.e020427.29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10620-015-3884-5","article-title":"Genetic biomarkers of Barrett\u2019s esophagus susceptibility and progression to dysplasia and cancer: a systematic review and meta-analysis","volume":"61","author":"Findlay","year":"2016","journal-title":"Dig Dis Sci"},{"key":"2025121408474956000_8.6.e020427.30","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-4-201302190-00009"},{"key":"2025121408474956000_8.6.e020427.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011190","article-title":"Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE","volume":"6","author":"Ensor","year":"2016","journal-title":"BMJ Open"},{"key":"2025121408474956000_8.6.e020427.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"2025121408474956000_8.6.e020427.33","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31826ddba6"},{"key":"2025121408474956000_8.6.e020427.34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1349-7006.2007.00663.x","article-title":"Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett\u2019s esophagus","volume":"99","author":"Cl\u00e9ment","year":"2008","journal-title":"Cancer Sci"},{"key":"2025121408474956000_8.6.e020427.35","doi-asserted-by":"publisher","DOI":"10.1002\/path.1884"},{"key":"2025121408474956000_8.6.e020427.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70016-2"},{"key":"2025121408474956000_8.6.e020427.37","doi-asserted-by":"publisher","DOI":"10.1038\/8816"},{"key":"2025121408474956000_8.6.e020427.38","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.300"},{"key":"2025121408474956000_8.6.e020427.39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208598"},{"key":"2025121408474956000_8.6.e020427.40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001890","article-title":"Three-tiered risk stratification model to predict progression in Barrett\u2019s esophagus using epigenetic and clinical features","volume":"3","author":"Sato","year":"2008","journal-title":"PLoS One"},{"key":"2025121408474956000_8.6.e020427.41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0028"},{"key":"2025121408474956000_8.6.e020427.42","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-1060"},{"key":"2025121408474956000_8.6.e020427.43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1442-2050.2012.01428.x","article-title":"Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett\u2019s esophagus","volume":"27","author":"Boerwinkel","year":"2014","journal-title":"Dis Esophagus"},{"key":"2025121408474956000_8.6.e020427.44","first-page":"3410","article-title":"Epigenetic patterns in the progression of esophageal adenocarcinoma","volume":"61","author":"Eads","year":"2001","journal-title":"Cancer Res"},{"key":"2025121408474956000_8.6.e020427.45","first-page":"S169","article-title":"Analysis of alterations in epithelial DNA methylation as potential epigenetic biomarkers of neoplastic progression in Barrett\u2019s Esophagus","volume":"1","author":"Puertas Canteria","year":"2012","journal-title":"Virchows Archiv"},{"key":"2025121408474956000_8.6.e020427.46","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-11-0364"},{"key":"2025121408474956000_8.6.e020427.47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600886"},{"key":"2025121408474956000_8.6.e020427.48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.18.9821"},{"key":"2025121408474956000_8.6.e020427.49","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.8.e32"},{"key":"2025121408474956000_8.6.e020427.50","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-547-7_9"},{"key":"2025121408474956000_8.6.e020427.51","doi-asserted-by":"publisher","DOI":"10.1038\/368753a0"},{"key":"2025121408474956000_8.6.e020427.52","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153634"},{"key":"2025121408474956000_8.6.e020427.53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2478\/v10039-012-0003-0","article-title":"p16 gene mutations in Barrett\u2019s esophagus in gastric metaplasia - intestinal metaplasia - dysplasia - adenocarcinoma sequence","volume":"57","author":"Mokrowiecka","year":"2012","journal-title":"Adv Med Sci"},{"key":"2025121408474956000_8.6.e020427.54","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309642"},{"key":"2025121408474956000_8.6.e020427.55","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1066-1"},{"key":"2025121408474956000_8.6.e020427.56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009972","article-title":"Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example","volume":"6","author":"Sekula","year":"2016","journal-title":"BMJ Open"},{"key":"2025121408474956000_8.6.e020427.57","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji184"},{"key":"2025121408474956000_8.6.e020427.58","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14686-7"},{"key":"2025121408474956000_8.6.e020427.59","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl338"},{"key":"2025121408474956000_8.6.e020427.60","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4184"},{"key":"2025121408474956000_8.6.e020427.61","first-page":"184","article-title":"Prognostic factors. Confusion caused by bad quality design, analysis and reporting of many studies","volume":"62","author":"Sauerbrei","year":"2005","journal-title":"Adv Otorhinolaryngol"},{"key":"2025121408474956000_8.6.e020427.62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001380"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-020427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:48:03Z","timestamp":1765730883000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-020427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,30]]},"published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1136\/bmjopen-2017-020427"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-020427","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}